Diagnostic Ultrasound
Novel property of nanotechnology platform to change imaging market
AION Diagnostics has discovered an innovative property to the Biosilicon nanotechnology platform that is set to impact the imaging market, including ultrasound. This technology is a unique biomaterial produced from elemental silicon. Its structure can be engineered to contain a 'honeycomb' of pores that allows BioSilicon to retain various compounds while also making it biodegradable. In fact, pre-clinical studies undertaken by its developer, pSivida, has shown that BioSilicon is both biodegradable and biocompatible. [More]
The use of high intensity focused ultrasound (HIFU) growing in Europe
The development of therapeutic applications has really accelerated over the past 15 years. This new treatment approach has now been recognised and its many advantages are appreciated. In particular, it is generally acknowledged that there are fewer side effects compared with other techniques. [More]
Ultrasound evolving to offer on-the-spot diagnostics
One message is clear — the recent release of a number of ultrasound devices demonstrates the need for more specialised, high-quality point-of-care systems to meet the growing demands for diagnosis on the spot. In response to that need, the ultrasound diagnostics market has witnessed an explosion of miniaturised devices that address one of the biggest challenges physicians face in caring for their high-risk patients – access to complete, real-time information that allows them to make clinical decisions with confidence at the patient’s bedside. [More]
